Pulmonary Distention Medical Services in China

Pulmonary distension (Fei Zhang) is a traditional Chinese medicine (TCM) syndrome characterized by chronic respiratory impairment, typically arising from prolonged exposure to external pathogens, phlegm-damp accumulation, or underlying deficiency of Lung, Spleen, and Kidney Qi. Clinically, it manifests as progressive dyspnea, wheezing, chest fullness, cough with copious sputum, cyanosis, and in advanced stages, cor pulmonale and right-sided heart failure—paralleling modern diagnoses such as chronic obstructive pulmonary disease (COPD), bronchiectasis, or interstitial lung disease. TCM management emphasizes pattern differentiation: common syndromes include Phlegm-Turbidity Obstructing the Lungs, Lung-Kidney Qi Deficiency, and Yang Deficiency with Water Retention. Treatment integrates herbal formulas (e.g., Su Zi Jiang Qi Tang or Zhen Wu Tang), acupuncture (targeting points like Dingchuan, Feishu, and Zhongfu), moxibustion, and Qigong-based pulmonary rehabilitation.

China offers distinct advantages for Pulmonary Distension care: world-class TCM hospitals—such as Guang’anmen Hospital and Shanghai University of Traditional Chinese Medicine—house nationally certified TCM pulmonologists with decades of clinical experience in integrative respiratory protocols. Advanced diagnostic tools—including high-resolution CT, pulmonary function testing, and real-time tongue/pulse analysis via AI-assisted TCM platforms—support precise pattern diagnosis. Published outcome studies report significant improvements in 6-minute walk distance, mMRC dyspnea scores, and exacerbation frequency after 12-week TCM interventions. Treatment costs are typically 40–60% lower than comparable integrative care in the US or EU, without compromising clinical rigor or safety standards.

As a dedicated medical tourism agency, we facilitate seamless access for international patients: verifying hospital credentials, coordinating appointments with senior TCM specialists, providing itemized, transparent pricing in advance, arranging medical visas, interpreters, and post-treatment follow-up—all within a single, culturally attuned support framework.

Treatment Options & Itemized Cost Breakdown for *Fei Zhang* (Pulmonary Distention)

Non-Surgical / Conservative Management

*Target Criteria:* Mild–moderate dyspnea, stable chronic bronchitis or COPD exacerbation, no acute respiratory failure.

• •TCM Herbal Decoction (Individualized Formula)

- 7-day decoction (raw herbs, pre-packaged granules): $35–$65 - Monthly follow-up + formula adjustment: $22–$33

• •Acupuncture + Moxibustion (Lung & Spleen Meridians)

- Standard course (12 sessions over 4 weeks): $216–$324

• •Diagnostic Workup (Essential Baseline)

- Chest X-ray (PA + lateral): $12 - Arterial blood gas (ABG): $24 - Complete blood count + CRP: $16

Surgical / Procedural Interventions

*Eligibility Criteria:* Severe emphysema with heterogeneous distribution, FEV₁ < 30% predicted, hyperinflation (RV/TLC > 150%), failed maximal medical therapy.

• •Bronchoscopic Lung Volume Reduction (BLVR) – Endobronchial Valves

- Procedure (valve placement in 1 lobe, single-session): $4,200–$5,800 - Post-op 3-month follow-up (including repeat PFTs + CT): $135

• •Surgical Lung Volume Reduction (LVRS)

- Procedure (open or VATS, bilateral resection): $8,600–$11,400 - 7-day hospital stay (ICU + ward, meds, nursing): $2,100–$2,800

Special/Complex Condition Management

• •Acute *Fei Zhang* with Right Heart Failure (Cor Pulmonale)

- Echocardiogram + right heart catheterization (if indicated): $185 - TCM emergency IV formulation (e.g., *Sheng Mai Yin* injection, 7-day course): $140

• •End-Stage *Fei Zhang* with Chronic Hypoxemia

- Annual maintenance + portable O₂ cylinder refills: $280

Quick Selection Guide

• •Age < 65, FEV₁ > 40%, budget <$500: Start with herbal decoction + acupuncture (12 sessions); total ~$350–$500.
• •Age 65–75, FEV₁ 20–35%, comorbid CAD/diabetes: BLVR preferred over LVRS; total procedural cost $4,500–$6,100.
• •Age > 75, FEV₁ < 20%, cor pulmonale: Prioritize home oxygen + ICU-capable palliative TCM support; avoid surgery.
• •Severe acute exacerbation + hypoxia (PaO₂ < 55 mmHg): Immediate ABG + ICU admission; avoid outpatient-only management.